Pharmaceutical industry

Legislation and Regulation

China emerges as world’s fastest-growing pharmaceutical industry

Here, we look at how China is emerging as the fastest-growing pharmaceutical sector in the world.

Growth Planning

How viable is the UK pharmaceuticals market for Amazon?

Amazon is eyeing up a lucrative new sector, the multi-billion pound pharmacy industry. But the UK medicines market might leave Amazon with a nasty taste in its mouth, warns ParcelHero's David Jinks.

Mergers & Acquisitions

Shire’s acquisition of NPS Pharmaceuticals ‘makes good sense’

Warwick Business School academic welcomes deal.


Abbey Pharma inks Business Growth Fund deal and closes acquisition

Kent-based Abbey Pharma has taken on external debt and equity finance so that it can support a planned buy-and-build strategy.


Angel CoFund makes investment in pharmaceutical space

Destiny Pharma has secured the investment capital it needs to finance a clinical trial for its drug aimed at dealing with antibiotic-resistant bacteria.

Mergers & Acquisitions

Penn Pharmaceuticals sale set to net LDC three times return on investment

LDC has exited a seven-year investment in Penn Pharmaceuticals by selling the healthcare-orientated business to Packaging Coordinators.


British medical company Acacia Pharma secures £15 million funding

A Series B venture capital financing round worth £15 million has been led by Fidelity Biosciences and Novo A/S.


YFM Equity Partners exits Fishawack in deal with Growth Capital Partners

Medical communications agency Fishawack has a new private equity backer through a secondary buy-out deal.


Mercury Pharma sold to Cinven three years after P2P

HgCapital has sold its interest in Mercury Pharma for a value of £465 million, marking its fifteenth portfolio company realisation in three years.


PsiOxus nets £22 million to commercialise cancer treatment

AIM-listed investment vehicle Imperial Innovations has backed PsiOxus Therapeutics in its Series B round.


North West Fund backs Evgen first close

Pharmaceutical business Evgen, a developer of a drug that may prevent and treat prostate cancer and other cancer, has closed a Series A investment round led by The North West Fund for Biomedical.


KalVista Pharmaceuticals launches on £8 million backing

Biotechnology company KalVista Pharmaceuticals has raised £8 million in a Series A financing round from life sciences venture investors Novo A/S and SV Life Sciences to develop a treatment for diabetes-related blindness.